Immediate Impact
1 by Nobel laureates 3 from Science/Nature 62 standout
Citing Papers
Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance
2024 Standout
The scope of the antimicrobial resistance challenge
2024 Standout
Works of Guy Lalonde being referenced
674. Pre-Clinical and Phase I Safety Data for Anti-Pseudomonas aeruginosa Human Monoclonal Antibody AR-105
2019
Alpha-hemolysin contributes to the pathogenicity of piliated digalactoside-binding Escherichia coli in the kidney: efficacy of an alpha-hemolysin vaccine in preventing renal injury in the BALB/c mouse model of pyelonephritis
1991
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Guy Lalonde | 155 | 184 | 81 | 156 | 24 | 614 | |
| Himal Luitel | 137 | 177 | 21 | 49 | 28 | 627 | |
| Marilena Galdiero | 211 | 75 | 84 | 39 | 32 | 737 | |
| Kunal P. Patel | 168 | 65 | 39 | 187 | 14 | 708 | |
| William D. Welch | 126 | 30 | 82 | 112 | 33 | 514 | |
| Xin Yuan | 216 | 21 | 102 | 108 | 42 | 688 | |
| Jörg Berg | 173 | 62 | 24 | 69 | 41 | 707 | |
| Shao‐Wen Hung | 194 | 23 | 20 | 113 | 47 | 631 | |
| Carles Saus | 128 | 12 | 88 | 69 | 22 | 556 | |
| Qiao Zhong | 118 | 28 | 16 | 72 | 35 | 582 | |
| Ian Toma | 267 | 54 | 9 | 105 | 24 | 595 |
All Works
Login with ORCID to disown or claim papers
Loading papers...